Cargando…

Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases

Detalles Bibliográficos
Autores principales:	Nakken, Britt, Alex, Philip, Munthe, Ludvig, Szekanecz, Zoltan, Szodoray, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310204/ https://www.ncbi.nlm.nih.gov/pubmed/22474487 http://dx.doi.org/10.1155/2012/957151

Ejemplares similares

Inflammatory Mediators in Autoimmunity and Systemic Autoimmune Diseases
por: Nakken, Britt, et al.
Publicado: (2015)

Pneumococcal vaccination in autoimmune rheumatic diseases
por: Rákóczi, Éva, et al.
Publicado: (2017)

Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases
por: Takakubo, Yuya, et al.
Publicado: (2012)

Selected Aspects in the Pathogenesis of Autoimmune Diseases
por: Nagy, György, et al.
Publicado: (2015)

Cognitive dysfunction in autoimmune rheumatic diseases
por: Oláh, Csaba, et al.
Publicado: (2020)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity
por: Szodoray, Peter, et al.
Publicado: (2021)

Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature
por: Bazsó, Anna, et al.
Publicado: (2015)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

Vascular involvement in rheumatic diseases: 'vascular rheumatology'
por: Szekanecz, Zoltán, et al.
Publicado: (2008)

T‐helper cell regulation of CD45 phosphatase activity by galectin‐1 and CD43 governs chronic lymphocytic leukaemia proliferation
por: Imbery, John F., et al.
Publicado: (2022)

Regulatory B cells in autoimmune rheumatic diseases
por: Sakkas, Lazaros I.
Publicado: (2017)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Biotechnological Drugs: The Breakthrough in Autoimmune Rheumatic Conditions
por: Cavagna, Lorenzo, et al.
Publicado: (2014)

Vaccination of patients with autoimmune inflammatory rheumatic disease: physicians’ perspectives
por: Moon, Ki Won
Publicado: (2023)

Mechanisms of hypertension in autoimmune rheumatic diseases
por: Taylor, Erin B., et al.
Publicado: (2019)

Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
por: Tulbă, Delia, et al.
Publicado: (2021)

Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis
por: Rentka, Anikó, et al.
Publicado: (2015)

POOR ADHERENCE TO DRUG TREATMENT IN CHILDREN AND ADOLESCENTS WITH AUTOIMMUNE RHEUMATIC DISEASES
por: Silva, Clovis Artur
Publicado: (2019)

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
por: Suresh, Lakshmanan
Publicado: (2021)

Autoimmune liver diseases in systemic rheumatic diseases
por: Wang, Chrong-Reen, et al.
Publicado: (2022)

The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren’s Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution
por: Szabó, Krisztina, et al.
Publicado: (2021)

Complex genetic association of 6q23 with autoimmune rheumatic conditions
por: Maxwell, James R, et al.
Publicado: (2009)

Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases
por: Brezovec, Neža, et al.
Publicado: (2021)

Biosimilars: To switch or not to switch – that is the question
por: Szekanecz, Zoltán
Publicado: (2020)

Cardiovascular Risk in Systemic Autoimmune Diseases: Epigenetic Mechanisms of Immune Regulatory Functions
por: López-Pedrera, Chary, et al.
Publicado: (2012)

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Vasculogenesis in rheumatoid arthritis
por: Szekanecz, Zoltán, et al.
Publicado: (2010)

Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease
por: Cutolo, Maurizio
Publicado: (2008)

The X in seX-biased immunity and autoimmune rheumatic disease
por: Jiwrajka, Nikhil, et al.
Publicado: (2022)

Molecular Mechanism of Rheumatic Diseases and Efficacy of Current Therapies
por: Umar, Sadiq, et al.
Publicado: (2017)

Curcumin in Autoimmune and Rheumatic Diseases
por: Yang, Melissa, et al.
Publicado: (2019)

Undifferentiated vasculitis or an evolving systemic autoimmune rheumatic disease?
por: Fatimah, Nafeesah, et al.
Publicado: (2016)

Humoral Autoimmunity in Systemic Rheumatic Disease: A Review
por: Bernstein, Robert M.
Publicado: (1990)

The potential role of 'non-rheumatic’ therapies in rheumatic disease
por: Massarotti, Elena M, et al.
Publicado: (2013)

Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases
por: Jankowska, Katarzyna, et al.
Publicado: (2023)

Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases
por: Gerasimova, Elena V., et al.
Publicado: (2022)

Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease
por: Guilherme, Luiza, et al.
Publicado: (2015)

The Course of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases
por: Rorat, Marta, et al.
Publicado: (2022)

Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management
por: De Zorzi, Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_33s1uvq7sc24bed98htq65aolr